000 | 01956 a2200553 4500 | ||
---|---|---|---|
005 | 20250514074138.0 | ||
264 | 0 | _c20030904 | |
008 | 200309s 0 0 eng d | ||
022 | _a0732-183X | ||
024 | 7 |
_a10.1200/JCO.2003.04.106 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aStrauss, S J | |
245 | 0 | 0 |
_aSingle center experience of a new intensive induction therapy for ewing's family of tumors: feasibility, toxicity, and stem cell mobilization properties. _h[electronic resource] |
260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cAug 2003 |
||
300 |
_a2974-81 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
650 | 0 | 4 | _aFeasibility Studies |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHematopoietic Stem Cell Mobilization |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIfosfamide _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMesna _xadministration & dosage |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aSarcoma, Ewing _xdrug therapy |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVincristine _xadministration & dosage |
700 | 1 | _aMcTiernan, A | |
700 | 1 | _aDriver, D | |
700 | 1 | _aHall-Craggs, M | |
700 | 1 | _aSandison, A | |
700 | 1 | _aCassoni, A M | |
700 | 1 | _aKilby, A | |
700 | 1 | _aMichelagnoli, M | |
700 | 1 | _aPringle, J | |
700 | 1 | _aCobb, J | |
700 | 1 | _aBriggs, T | |
700 | 1 | _aCannon, S | |
700 | 1 | _aWitt, J | |
700 | 1 | _aWhelan, J S | |
773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 21 _gno. 15 _gp. 2974-81 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2003.04.106 _zAvailable from publisher's website |
999 |
_c12662757 _d12662757 |